(R,R,R,R,4S,4'S,4''S,5R,5'R,5''R,6R,6'R,6''R)-2,2',2''-(14S,14'S,14''S,20S,20'S,20''S,23S,23'S,23''S,26S,26'S,26''S,32S,32'S,32''S)-1,1',1''-(benzene-1,3,5-triyl)tris(14,20,26,32-tetrakis(hydroxymethyl)-23-methyl-1,10,13,16,19,22,25,28,31,34,37-undecaoxo-2'',9'',12'',15'',18'',21'',24'',27'',30'',33'',36''-undecaazahentetracontane-41,1-diyl)tris(oxy)tris(5-acetamido-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid)

ID: ALA4878363

Chembl Id: CHEMBL4878363

PubChem CID: 164626891

Max Phase: Preclinical

Molecular Formula: C144H234N36O72

Molecular Weight: 3621.64

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(OCCCCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCCCCCCNC(=O)c2cc(C(=O)NCCCCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CCCCOC3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)cc(C(=O)NCCCCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)CCCCOC3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)c2)(C(=O)O)C[C@@H]1O

Standard InChI:  InChI=1S/C144H234N36O72/c1-70(163-136(238)88(64-190)175-109(217)52-157-130(232)82(58-184)169-103(211)46-151-97(205)25-13-22-34-247-142(139(241)242)40-91(199)112(166-73(4)196)118(250-142)115(220)94(202)67-193)121(223)178-85(61-187)133(235)160-49-106(214)172-79(55-181)127(229)154-43-100(208)145-28-16-7-10-19-31-148-124(226)76-37-77(125(227)149-32-20-11-8-17-29-146-101(209)44-155-128(230)80(56-182)173-107(215)50-161-134(236)86(62-188)179-122(224)71(2)164-137(239)89(65-191)176-110(218)53-158-131(233)83(59-185)170-104(212)47-152-98(206)26-14-23-35-248-143(140(243)244)41-92(200)113(167-74(5)197)119(251-143)116(221)95(203)68-194)39-78(38-76)126(228)150-33-21-12-9-18-30-147-102(210)45-156-129(231)81(57-183)174-108(216)51-162-135(237)87(63-189)180-123(225)72(3)165-138(240)90(66-192)177-111(219)54-159-132(234)84(60-186)171-105(213)48-153-99(207)27-15-24-36-249-144(141(245)246)42-93(201)114(168-75(6)198)120(252-144)117(222)96(204)69-195/h37-39,70-72,79-96,112-120,181-195,199-204,220-222H,7-36,40-69H2,1-6H3,(H,145,208)(H,146,209)(H,147,210)(H,148,226)(H,149,227)(H,150,228)(H,151,205)(H,152,206)(H,153,207)(H,154,229)(H,155,230)(H,156,231)(H,157,232)(H,158,233)(H,159,234)(H,160,235)(H,161,236)(H,162,237)(H,163,238)(H,164,239)(H,165,240)(H,166,196)(H,167,197)(H,168,198)(H,169,211)(H,170,212)(H,171,213)(H,172,214)(H,173,215)(H,174,216)(H,175,217)(H,176,218)(H,177,219)(H,178,223)(H,179,224)(H,180,225)(H,241,242)(H,243,244)(H,245,246)/t70-,71-,72-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94+,95+,96+,112+,113+,114+,115+,116+,117+,118+,119+,120+,142?,143?,144?/m0/s1

Standard InChI Key:  ZNEXIWATCZIZEH-SHNFIKKFSA-N

Alternative Forms

  1. Parent:

    ALA4878363

    ---

Associated Targets(non-human)

HA Hemagglutinin (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 3621.64Molecular Weight (Monoisotopic): 3619.5756AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Shao L, Yang F, Su Y, Li W, Zhang J, Xu H, Huang B, Sun M, Mu Y, Zhang Y, Yu F..  (2021)  Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry.,  12  (11.0): [PMID:34795865] [10.1021/acsmedchemlett.1c00374]

Source